The SNS account of a medical-related company that has doubts about the Chinese government-recommended ``herbal medicine that is effective against the new corona'' will be frozen
Since the early days of the epidemic of the new coronavirus infection (COVID-19), the Chinese government has made the claim that 'Chinese medicine is effective in preventing and treating COVID-19 infection.' Regarding such Chinese herbal medicines recommended by the Chinese government, it is reported that the SNS account of a Chinese medical information company that published an article questioning the effectiveness of COVID-19 was frozen and new posts were prohibited.
DXY Weibo Ban: China Health Information Provider Social Media Accounts Go Silent - Bloomberg
China suspends major platform that doubted Beijing COVID policies - Nikkei Asia
https://asia.nikkei.com/Spotlight/Coronavirus/China-suspends-major-platform-that-doubted-Beijing-COVID-policies
Hangzhou Lianke Meixun Biomedical Technology Co., Ltd. (DXY) , a medical information dissemination company in China, conducts fact-checks on various health-related information and disseminates accurate scientific knowledge to the general public. We operate a website that explains DXY received investments from companies such as IDG Capital and Tencent in China, and in 2020 the market capitalization exceeded $ 1 billion (about 130 billion yen).
On the other hand, the Chinese government has been claiming that traditional Chinese medicine such as acupuncture and herbal medicine is effective in treating COVID-19 since the early days of the COVID-19 epidemic, and in the spring of 2022, COVID-19 was prevalent in Hong Kong. Distributing herbal medicines .
In response, DXY published an article stating that the Chinese government-recommended Chinese herbal medicine ``Renka Seion'', which was distributed in Hong Kong, ``has not been confirmed to be effective in preventing COVID-19 infection.'' . He also expressed suspicion that Lianhua Qingxiang was distributed prior to food and other necessities during thelockdown in Shanghai . This article has already been deleted, but it is said that Chinese net users have gathered criticism such as 'Chinese medicine criticism'.
About three months after DXY published an article questioning the effectiveness of Renhua Seisho, at least five social media accounts run by DXY were frozen and banned from posting new posts. The Weibo account has been labeled as 'violating terms,' but no further details were provided. It seems that the censored account has a total of 8.69 million followers.
In recent years, the Chinese government has adopted a policy of actively promoting traditional Chinese medicine, and is promoting treatment with Chinese herbal medicine for COVID-19. Outside of Japan, the company is also dispatching herbal medicine experts to Cambodia and supporting clinical trials of COVID-19 treatment using herbal medicine in Pakistan. Chinese herbal medicine manufacturers are benefiting from this, with Yiling Pharmaceutical Co. , the manufacturer of Lianhua Qingxiang, expecting Lianhua Qingxiang to generate 4.1 billion yuan (approximately 81 billion yen) in 2021. reported to have brought in sales.
Bloomberg requested comments from the China Cyberspace Administration (CAC), which is responsible for Internet censorship in China, WeChat's parent company Tencent, Weibo, DXY, etc., but none of them responded. That's it.
Related Posts:
in Web Service, Science, Posted by log1h_ik